EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs

Maxim E Zhidkov, Maria A Sidorova, Polina A Smirnova iD, Oleg A Tryapkin iD, Andrey V Kachanov, Alexey V Kantemirov iD, Lyubov G Dezhenkova, Natalia E Grammatikova, Elena B Isakova, Andrey E Shchekotikhin iD, Marina A Pak, Olga N Styshova und 2 weitere

Marine Drugs · 2024

DOI: 10.3390/md22020053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Maxim E Zhidkov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Materials, Institute of High Technologies and Advanced Materials, FEFU Campus, Far Eastern Federal University, Ajax Bay 1…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Anti-Infective Agents, Quaternary Ammonium Compounds, Carbolines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Far Eastern Federal University, the Ministry of Science and Higher Education of the Russian Federation, Russian Foundation for Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the results of our own preliminary studies, the derivative of the marine alkaloid fascaplysin containing a phenyl substituent at C-9 was selected to evaluate the therapeutic potential in vivo and in vitro. It was shown that this compound has outstandingly high antimicrobial activity against Gram-positive bacteria, including antibiotic-resistant strains in vitro. The presence of a substituent at C-9 of the framework is of fundamental importance, since its replacement to neighboring positions leads to a sharp decrease in the selectivity of the antibacterial action, which indicates the presence of a specific therapeutic target in bacterial cells. On a model of the acute bacterial sepsis in mice, it was shown that the lead compound was more effective than the reference antibiotic vancomycin seven out of nine times. However, ED50 value for 9-phenylfascaplysin (7) was similar for the unsubstituted fascaplysin (1) in vivo, despite the former being significantly more active than the latter in vitro. Similarly, assessments of the anticancer activity of compound 7 against various variants of Ehrlich carcinoma in mice demonstrated its substantial efficacy. To conduct a structure–activity relationship (SAR) analysis and searches of new candidate compounds, we synthesized a series of analogs of 9-phenylfascaplysin with varying aryl substituents. However, these modifications led to the reduced aqueous solubility of fascaplysin derivatives or caused a loss of their antibacterial activity. As a result, further research is required to explore new avenues for enhancing its pharmacokinetic characteristics, the modification of the heterocyclic framework, and optimizing of treatment regimens to harness the remarkable antimicrobial potential of fascaplysin for practical usage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAnti-Infective AgentsQuaternary Ammonium CompoundsCarbolinesIndolizinesAnimalsMiceStructure-Activity RelationshipIndolesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

9-phenylfascaplysinantibacterial activityantiproliferative activityantitumor activityfascaplysin derivatives

Substanzen

fascaplysineAnti-Bacterial AgentsIndolesAnti-Infective AgentsQuaternary Ammonium CompoundsCarbolinesIndolizines

Autor:innen und Institutionen

  • Department of Chemistry and Materials, Institute of High Technologies and Advanced Materials, FEFU Campus, Far Eastern Federal University, Ajax Bay 10, Russky Island, 690922 Vladivostok, Russia.
  • Laboratory of Chemical Transformation of Antibiotics, Gause Institute of New Antibiotics, 119021 Moscow, Russia.
  • Departments of Biotechnology and Marine Natural Compounds Chemistry, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of The Russian Academy of Sciences, 690922 Vladivostok, Russia.

ORCID-Profile: Polina A Smirnova, Oleg A Tryapkin, Alexey V Kantemirov, Andrey E Shchekotikhin

Förderung

  • Far Eastern Federal University
  • the Ministry of Science and Higher Education of the Russian Federation
  • Russian Foundation for Basic Research
  • Ministry of Science and Higher Education of the Russian Federation
  • RFBR

Zitieren

APA

Zhidkov, M. E., Sidorova, M. A., Smirnova, P. A., Tryapkin, O. A., Kachanov, A. V., Kantemirov, A. V., Dezhenkova, L. G., Grammatikova, N. E., Isakova, E. B., Shchekotikhin, A. E., Pak, M. A., Styshova, O. N., Klimovich, A. A., & Popov, A. M. (2024). Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs. Marine Drugs. https://doi.org/10.3390/md22020053

Vancouver

Zhidkov ME, Sidorova MA, Smirnova PA, Tryapkin OA, Kachanov AV, Kantemirov AV, et al. Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs. Marine Drugs. 2024. doi:10.3390/md22020053

BibTeX
@article{Zhidkov2024,
  author = {Zhidkov, Maxim E and Sidorova, Maria A and Smirnova, Polina A and Tryapkin, Oleg A and Kachanov, Andrey V and Kantemirov, Alexey V and Dezhenkova, Lyubov G and Grammatikova, Natalia E and Isakova, Elena B and Shchekotikhin, Andrey E and Pak, Marina A and Styshova, Olga N and Klimovich, Anna A and Popov, Aleksandr M},
  title = {Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22020053}
}
Kostenlos starten →